Event
Meet Axxam at BIO Asia–Taiwan 2026
Anzai Takayuki
BD Advisor- BD & Sales Asia & Pacific
Axxam at the BIO Asia–Taiwan 2026
Axxam is pleased to participate in BIO Asia–Taiwan 2026, one of Asia’s leading biotechnology conferences, bringing together pharmaceutical companies, biotech innovators, research organizations, investors, and technology providers from around the world.
Join us in Taipei to discover how Axxam’s integrated early drug discovery services help accelerate research programs from target validation through hit identification and lead optimization support.
Whether you are looking for a trusted discovery partner, exploring new technologies, or seeking scientific expertise for your next project, we look forward to meeting you.
Axxam Company Presentation at BIO Asia–Taiwan 2026
Don’t miss our company presentation during the exhibition.
- Thursday, July 16
- 15:00 – 15:15
- Booth No. N913 – Exhibition Area, 4F, TaiNEX Hall 1
During this presentation, our Japanese Business Development Advisor, Takayuki Anzai, will introduce Axxam’s integrated drug discovery capabilities and highlight how our scientific platforms support efficient decision-making throughout the early stages of drug discovery research.
The presentation will provide an overview of our expertise in assay development, screening technologies, translational biology, and collaborative discovery programs designed to help researchers generate robust, actionable data.
Visit Axxam at Booth N913
Our Japanese Business Development Advisor, Takayuki Anzai, will be available throughout the exhibition to discuss your drug discovery challenges and explore how Axxam can support your research objectives.
Meet with us to learn more about our scientific capabilities across multiple therapeutic areas and technology platforms, including:
- Capabilities:
- Target ID and validation
- Assay development
- High-throughput screening (HTS)
- Compound library management
- Hit identification and hit characterization
- Early ADME and profiling
- Human iPSC-derived disease models
- Theraupetic areas:
- Neurodegeneration
- Oncology
- Metabolic
- Rare disease discovery
Whether your program is at an early exploratory stage or progressing toward lead optimization, our multidisciplinary teams work closely with biotechnology and pharmaceutical companies to deliver flexible, high-quality discovery solutions.
Why meet with Axxam?
Drug discovery is becoming increasingly complex, requiring access to specialized technologies, diverse scientific expertise, and reliable experimental data.
For more than two decades, Axxam has supported pharmaceutical, biotechnology, start-up, and academic organizations worldwide with integrated discovery services that combine biology, chemistry, automation, and data-driven approaches.
Our teams support projects across a broad range of therapeutic areas, helping clients accelerate discovery timelines while generating high-quality data to support informed project decisions.
Whether your focus is neuroscience, oncology, inflammation, cardiometabolic diseases, rare diseases, or other therapeutic areas, we tailor our approach to the specific scientific questions and project goals.
Schedule a Meeting
If you are planning to attend BIO Asia–Taiwan 2026, we would be delighted to meet you.
Visit us at Booth N913 or contact us in advance to schedule a meeting with Takayuki Anzai.
We look forward to discussing how Axxam can help accelerate your next drug discovery program.